Sigma Healthcare Selloff Attracts New Bulls -- Market Talk

Dow Jones12-12 08:20

0020 GMT - Sigma Healthcare gets a new pair of new bulls at Morgans, where analysts see the pharmaceutical retailer and supplier as one of Australia's highest growth health stocks. Analysts Scott Power and Emily Porter raise their recommendation to buy from accumulate on recent share-price weakness, telling clients in a note that they still forecast consistent EPS growth of about 20% over the next three years. They don't envisage any problems from union negotiations and expect an agreement on terms for employees at its Chemist Warehouse retail chain. Management's focus on integrating the Chemist Warehouse and supply businesses support the analysts' confidence in revenue and earnings growth. Morgans has a A$3.39 target price on the stock, which is up 0.9% at A$2.905. (stuart.condie@wsj.com)

(END) Dow Jones Newswires

December 11, 2025 19:20 ET (00:20 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2590754024?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-12 08:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2590754024","market":"us","top_or_hot":-1,"title":"Sigma Healthcare Selloff Attracts New Bulls -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0020 GMT - <a href=\"https://laohu8.com/S/SIGGF\">Sigma Healthcare</a> gets a new pair of new bulls at Morgans, where analysts see the pharmaceutical retailer and supplier as one of Australia's highest growth health stocks. Analysts Scott Power and Emily Porter raise their recommendation to buy from accumulate on recent share-price weakness, telling clients in a note that they still forecast consistent EPS growth of about 20% over the next three years. They don't envisage any problems from union negotiations and expect an agreement on terms for employees at its Chemist Warehouse retail chain. Management's focus on integrating the Chemist Warehouse and supply businesses support the analysts' confidence in revenue and earnings growth. Morgans has a A$3.39 target price on the stock, which is up 0.9% at A$2.905. (stuart.condie@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 11, 2025 19:20 ET (00:20 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sigma Healthcare Selloff Attracts New Bulls -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSigma Healthcare Selloff Attracts New Bulls -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-12-12 08:20</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0020 GMT - <a href=\"https://laohu8.com/S/SIGGF\">Sigma Healthcare</a> gets a new pair of new bulls at Morgans, where analysts see the pharmaceutical retailer and supplier as one of Australia's highest growth health stocks. Analysts Scott Power and Emily Porter raise their recommendation to buy from accumulate on recent share-price weakness, telling clients in a note that they still forecast consistent EPS growth of about 20% over the next three years. They don't envisage any problems from union negotiations and expect an agreement on terms for employees at its Chemist Warehouse retail chain. Management's focus on integrating the Chemist Warehouse and supply businesses support the analysts' confidence in revenue and earnings growth. Morgans has a A$3.39 target price on the stock, which is up 0.9% at A$2.905. (stuart.condie@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 11, 2025 19:20 ET (00:20 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4581","symbol_name":"高盛持仓","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2590754024","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2590754024","pubTimestamp":1765498800,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0020 GMT - Sigma Healthcare gets a new pair of new bulls at Morgans, where analysts see the pharmaceutical retailer and supplier as one of Australia's highest growth health stocks. Analysts Scott Power and Emily Porter raise their recommendation to buy from accumulate on recent share-price weakness, telling clients in a note that they still forecast consistent EPS growth of about 20% over the next three years. They don't envisage any problems from union negotiations and expect an agreement on terms for employees at its Chemist Warehouse retail chain. Management's focus on integrating the Chemist Warehouse and supply businesses support the analysts' confidence in revenue and earnings growth. Morgans has a A$3.39 target price on the stock, which is up 0.9% at A$2.905. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4581":"高盛持仓","BK4137":"综合支持服务","BK4588":"碎股","BK7103":"保健护理产品经销商","SIG.AU":"SIGMA HEALTHCARE LTD","BK4585":"ETF&股票定投概念","LU0128526141.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" ACC","LU0029874061.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" YDIS INC","XLV":"健康照护类股ETF-SPDR","HCSG":"Healthcare Svcs Group Inc","XBI":"SPDR S&P Biotech ETF","LABU":"三倍做多标普生物-Direxion"},"translate_title":"Sigma Healthcare抛售吸引了新的多头——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LABU":0.6,"XLV":1.5,"HCSG":1.5,"SIG.AU":0.9,"XBI":0.6},"content_text":"0020 GMT - Sigma Healthcare gets a new pair of new bulls at Morgans, where analysts see the pharmaceutical retailer and supplier as one of Australia's highest growth health stocks. Analysts Scott Power and Emily Porter raise their recommendation to buy from accumulate on recent share-price weakness, telling clients in a note that they still forecast consistent EPS growth of about 20% over the next three years. They don't envisage any problems from union negotiations and expect an agreement on terms for employees at its Chemist Warehouse retail chain. Management's focus on integrating the Chemist Warehouse and supply businesses support the analysts' confidence in revenue and earnings growth. Morgans has a A$3.39 target price on the stock, which is up 0.9% at A$2.905. (stuart.condie@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 11, 2025 19:20 ET (00:20 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2590754024","isCrawlerRequest":true}